首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Optimization and validation of a dissolution test for selegiline hydrochloride tablets by a novel rapid HPLC assay using a monolithic stationary phase.
【24h】

Optimization and validation of a dissolution test for selegiline hydrochloride tablets by a novel rapid HPLC assay using a monolithic stationary phase.

机译:盐酸司来吉兰片的溶出度测试的优化和验证是通过使用整体固定相的新型快速HPLC分析进行的。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study reports the optimization and validation of a dissolution test for selegiline.HCl tablets using a new high-performance liquid chromatographic (HPLC) method. Rapid separation of the analyte from sample matrix was achieved in less than 60s using a Cromolith((R)) RP-18e monolithic column using UV detection at 220nm. Thorough validation of the assay based on pre-defined criteria included linearity, LOD/LOQ, accuracy, precision, selectivity and ruggedness. The dissolution test was optimized in terms of dissolution medium, basket (type I)/paddle (type II) agitation and rotation speed. Its ruggedness was also validated. The presented analytical and dissolution procedures are currently being applied in the quality and stability control of Cosmopril((R)) tablets (5mg/tablet selegiline.HCl, Cosmopharm Ltd., Korinthos, Greece).
机译:本研究报告了使用新型高效液相色谱(HPLC)方法对司来吉兰.HCl片进行溶出度测试的优化和验证。使用Cromolith RP-18e整体式色谱柱,在220nm处进行UV检测,可在不到60s的时间内将分析物与样品基质快速分离。根据预先定义的标准对测定进行全面验证,包括线性,LOD / LOQ,准确性,精密度,选择性和耐用性。在溶出介质,篮式(I型)/桨式(II型)搅拌和转速方面对溶出度测试进行了优化。其坚固性也得到了验证。提出的分析和溶解程序目前正用于Cosmopril片剂(5mg /片司来吉兰HCl,Cosmopharm Ltd.,Korinthos,希腊)的质量和稳定性控制中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号